DIM1HEALTH is based on three areas – environmental health, human health and animal health – whose close interactions make them inseparable from each other. The “One Health” concept came into being in a context characterized by climate change, worldwide demographic growth, scarcity of natural resources, and shifting health pressures in both human and animal populations.

L’attribut alt de cette image est vide, son nom de fichier est ONE-HEALTH-INTERVENTION.png.
Préannonce: Interventions permettant la prévention et la réduction de la transmission des facteurs de résistance aux antibiotiques en utilisant une approche “One Health”

Enveloppe Globale : 24, 9 millions d’euros

Enveloppe ANR pour les equipes Françaises : 2 millions d’euros plus une  contribution UE qui sera fonction du nombre de projets francais  retenus –   450 000 € max par projet pour les équipes françaises

Ouverture: 14 -Janvier 2021  –    Date butoir préposition  16 mars 2021

Domaines d’intérêt :

  • Comprendre l’impact des interventions préalablement menées sur la transmission de la résistance aux antibiotiques
  • Développer, conduire et évaluer des interventions innovantes afin de mieux maitriser la transmission de la résistance aux antibiotiques
  • Les projets devront intégrer au moins 2 composantes «  One_Health : Santé publique, Santé Environnementale, Santé animale

Pays participants : Allemagne -Argentine – Belgique – Canada- Danemark –Espagne- Estonie – Finlande – France – Allemagne –Hongrie -Irlande – Irlande – Israël – Italie -Lettonie – Lituanie -Moldavie  – Norvège -Pays bas – Royaume –uni  -Suède

Composition des consortiums : minimum: 3 partenaires /3 pays éligibles  dont 2 pays Européens ou associés- Maximum: 6 partenaires, (7 en présence de pays sous représentés)

L’implication de pays à indice faible et moyen de développement économique est encouragée

Contacts JPI-AMRCalls@agencerecherche.fr  

Sophie Gay : 01 78 09 80 39

Ingrid Pfeifer : 01 78 09 80 22

https://www.jpiamr.eu/

Paris Region PhD 2021

The Region supports scientific employment in line with the needs of businesses by co-financing doctoral grants. Projects relating to an area of ​​major interest and associating a laboratory and a company are eligible.

More information onhttps://www.iledefrance.fr/paris-region-phd-2021

THE « ONE HEALTH DAY» IS NOVEMBER 3, 2020



It is an initiative that gives scientists and advocates for our planet a voice to go beyond current approaches to emerging zoonotic infectious diseases, resistance to anti-infectives, climate change, the impacts of air pollution. environment, food safety (think pure water so scarce in much of the world), comparative / translational medicine, and a holistic default way of doing research, expertise or trade. It is also moving towards more cooperation in research with the integration of a “sustainable and economical laboratory”.
Launched in April 2016 by three major international groups One Health, the “One Health Commission”, the “One Health Initiative Autonomous Pro Bono Team” and the “One Health Platform Foundation”, the World “One Health” Day has become an annual platform for users of the One Health concept all over the world. Anyone, from academia to the private sector, businesses and government agencies, can run One Health Day events. In short, it is a day for cooperation, creativity, education. That day, DIM1HEALTH will publish a special issue of 5 articles in the international journal Parasite “One health: a social science discussion of a global agenda”, guest editors Jean Estebanez and Pascal Boireau. Work supported by DIM1HEALTH will be published.

Call for proposals 2020

The Major Areas of Interest (DIM) initiated by the Île-de-France region are a flagship scheme that aims to unify the laboratory networks located in Île-de-France by acting upon targeted accredited areas.

Find out more about the call for proposals

COVID-19: Following the Coronavirus epidemic, the deadline for the call for proposals is now May 15, 2020